124 related articles for article (PubMed ID: 2146242)
21. Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya.
MacDonald KS; Cameron DW; D'Costa L; Ndinya-Achola JO; Plummer FA; Ronald AR
Antimicrob Agents Chemother; 1989 May; 33(5):612-4. PubMed ID: 2502065
[TBL] [Abstract][Full Text] [Related]
22. Cefotaxime treatment of Haemophilus ducreyi infection in Kenya.
Plummer FA; Maggwa N; D'Costa LJ; Nsanze H; Karasira P; Maclean IW; Ronald AR
Sex Transm Dis; 1984; 11(4):304-7. PubMed ID: 6098034
[TBL] [Abstract][Full Text] [Related]
23. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.
Knapp JS; Back AF; Babst AF; Taylor D; Rice RJ
Antimicrob Agents Chemother; 1993 Jul; 37(7):1552-5. PubMed ID: 8363390
[TBL] [Abstract][Full Text] [Related]
24. Chancroid in Sheffield. A report of 22 cases diagnosed by isolating Haemophilus ducreyi in a modified medium.
Hafiz S; Kinghorn GR; McEntegart MG
Br J Vener Dis; 1981 Dec; 57(6):382-6. PubMed ID: 6976815
[TBL] [Abstract][Full Text] [Related]
25. Treating chancroid: summary of studies in southern Africa.
Ballard RC; Duncan MO; Fehler HG; Dangor Y; Exposto FL; Latif AS
Genitourin Med; 1989 Jan; 65(1):54-7. PubMed ID: 2629710
[TBL] [Abstract][Full Text] [Related]
26. Drug resistance of Haemophilus ducreyi.
Rutanarugsa A; Vorachit M; Polnikorn N; Jayanetra P
Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):185-93. PubMed ID: 2237585
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology, clinical features, diagnosis and treatment of Haemophilus ducreyi - a disappearing pathogen?
Lewis DA
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):687-96. PubMed ID: 24597521
[TBL] [Abstract][Full Text] [Related]
28. Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to trimethoprim-sulfamethoxazole.
Bogaerts J; Kestens L; Martinez Tello W; Akingeneye J; Mukantabana V; Verhaegen J; Van Dyck E; Piot P
Clin Infect Dis; 1995 Apr; 20(4):924-30. PubMed ID: 7795096
[TBL] [Abstract][Full Text] [Related]
29. National guideline for the management of chancroid. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Sex Transm Infect; 1999 Aug; 75 Suppl 1():S43-5. PubMed ID: 10616383
[No Abstract] [Full Text] [Related]
30. Chancroid and granuloma inguinale.
Ronald AR; Plummer FA
Clin Lab Med; 1989 Sep; 9(3):535-43. PubMed ID: 2676322
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous chancroid in a visitor from Vanuatu.
McBride WJ; Hannah RC; Le Cornec GM; Bletchly C
Australas J Dermatol; 2008 May; 49(2):98-9. PubMed ID: 18412810
[TBL] [Abstract][Full Text] [Related]
32. Treatment of chancroid.
J Am Acad Dermatol; 1983 Jan; 8(1):128-32. PubMed ID: 6600752
[No Abstract] [Full Text] [Related]
33. In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
Ismaeel NA
Microbios; 1993; 74(299):103-9. PubMed ID: 8361391
[TBL] [Abstract][Full Text] [Related]
34. UK National Guideline for the management of Chancroid 2014.
O'Farrell N; Lazaro N
Int J STD AIDS; 2014 Dec; 25(14):975-83. PubMed ID: 25080286
[No Abstract] [Full Text] [Related]
35. Evaluation of 500- and 1,000-mg doses of ciprofloxacin for the treatment of chancroid.
Bodhidatta L; Taylor DN; Chitwarakorn A; Kuvanont K; Echeverria P
Antimicrob Agents Chemother; 1988 May; 32(5):723-5. PubMed ID: 3293526
[TBL] [Abstract][Full Text] [Related]
36. Trimethoprim sulphamoxole in the treatment of chancroid. Comparison of two single dose treatment regimens with a five day regimen.
Dylewski J; Nsanze H; D'Costa L; Slaney L; Ronald A
J Antimicrob Chemother; 1985 Jul; 16(1):103-9. PubMed ID: 3876325
[TBL] [Abstract][Full Text] [Related]
37. Thiamphenicol in the treatment of chancroid in men.
Latif AS; Crocchiolo PR; Lencioni R
Sex Transm Dis; 1984; 11(4 Suppl):454-5. PubMed ID: 6335300
[TBL] [Abstract][Full Text] [Related]
38. A prospective clinical and bacteriologic study of inguinal buboes in Thai men.
Viravan C; Dance DA; Ariyarit C; Looareesuwan S; Wattanagoon Y; Davis TM; Wuthiekanun V; Tantivanich S; Angus BJ; White NJ
Clin Infect Dis; 1996 Feb; 22(2):233-9. PubMed ID: 8838178
[TBL] [Abstract][Full Text] [Related]
39. Fleroxacin in the treatment of chancroid: an open study in men seropositive or seronegative for the human immunodeficiency virus type 1.
Tyndall MW; Plourde PJ; Agoki E; Malisa W; Ndinya-Achola JO; Plummer FA; Ronald AR
Am J Med; 1993 Mar; 94(3A):85S-88S. PubMed ID: 8452188
[TBL] [Abstract][Full Text] [Related]
40. Chancroid: clinical manifestations, diagnosis, and management.
Lewis DA
Sex Transm Infect; 2003 Feb; 79(1):68-71. PubMed ID: 12576620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
